Posted by West on August 11, 2008, at 16:00:05
In reply to Re: Amphetamine neurotoxicity in therapeutic doses, posted by dbc on August 10, 2008, at 16:46:38
>>But what is the point? I wonder what Anon would think of benzo.org, im sure they'd be interested in the forum.
I originally decided to ignore this post since the one you posted prior to it seemed rather confused and off-topic, i thought you'd lost your way a bit since we were discussing amphetamines not benzos. If you're trying to portray me as some kind of extremist out to chastise unwell people then i can promise you that i am not that person having suffered depression and anxiety for 6 years myself.
My concern is that tons of americans and their children are taking this drug in good faith without knowing about its neuropharmacology and i'm sure that, if they knew more about its action, they would open themselves up to making more educated decisions when it comes to treating their ADD/ADHD. The layman for instance might, when asked which treatment he preferred, settle on adderall, perhaps saying 'it was the only one that worked' for him when plausibly he might just have preferred the feeling it engendered in him, unaware of amphetamine's euphoric effects. Who wouldn't prefer a drug which directly arouses feelings of interest and pleasure- it's a neurochemical non sequitur.
So a second issue exists with their safety which is marginalised by the drug's strong reinforcing effects, to me nothing spells trouble like a potent releaser of monoamines. MDMA + MDA are both examples of phenylethlamines known to induce the redistribution and release of chemicals in the brain; both are well documented neurotoxins.
I just read a study which i will look for again which attributed d-amphetamine's primary neurotoxic effects at room temperature to hypothermia, similar effects were seen with ephedrine I believe.
poster:West
thread:845093
URL: http://www.dr-bob.org/babble/20080805/msgs/845548.html